Press release content from Newswire. The AP news staff was not involved in its creation.
CityHealth Urgent Care Opens New COVID-19 Testing Locations in Dublin & Livermore
January 22, 2021 GMT
Livermore, CA & Dublin, CA COVID-19 Testing
DUBLIN, Calif. & LIVERMORE, Calif. - January 21, 2021 - ( Newswire.com )
CityHealth Urgent Care today announced the opening of two new COVID-19 testing locations, this time to serve the residents of the Tri-Valley and San Francisco Bay Area.
A Dublin testing site is open at 5380 Broder Blvd., Dublin. It will be open every day from 10 AM - 7 PM.
“CityHealth has been a great partner in our fight against COVID-19 in Alameda County. We are very pleased with the addition of the new testing site at the Santa Rita Jail campus. This location will provide much needed testing to eastern Alameda County and first responders who serve our communities,” said Gregory J. Ahern, Alameda County Sheriff
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Collection Sites Announces Partnership with Health and Wellness Expert, Heidi Powell
Medivolve Inc.January 21, 2021 GMT
TORONTO, Jan. 21, 2021 (GLOBE NEWSWIRE) Medivolve, Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) is pleased to announce the launch of a partnership between its wholly owned subsidiary, Collection Sites, LLC, and Heidi Powell, fitness and transformation expert from ABC’s ‘Extreme Weight Loss’ show. Furthering its dedication to flatten the curve against the novel coronavirus, Collection Sites and Heidi Powell have launched two COVID-19 testing centers in Austin, Texas and Tempe, Arizona providing convenient access to rapid antibody and antigen tests. As part of the partnership, Heidi Powell has paid an upfront fee to launch the test centre in exchange for a small royalty. Through this partnership, Collection Sites customers nationwide will have access to H
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Sophos Identifies Source Of “MrbMiner” Attacks Targeting Database Servers
Sophos Ltd.January 21, 2021 GMT
OXFORD, United Kingdom, Jan. 21, 2021 (GLOBE NEWSWIRE) Sophos, a global leader in next-generation cybersecurity, today published a new report on MrbMiner, “ MrbMiner: Cryptojacking to bypass international sanctions,” tracking its origin and management to a small software development company based in Iran.
ADVERTISEMENT
MrbMiner is a recently discovered cryptominer that targets internet-facing database servers (SQL servers) and downloads and installs a cryptominer. Database servers are an attractive target for cryptojackers because they are used for resource intensive activity and therefore have powerful processing capability.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
REPEAT Metallica Metals Provides Corporate Update
Metallica Metals CorpJanuary 21, 2021 GMT
VANCOUVER, British Columbia, Jan. 21, 2021 (GLOBE NEWSWIRE) Metallica Metals Corp. (CSE: MM) (OTC: CRUUF) (FWB: SY7P) (the “Company” or “Metallica Metals”) is pleased to announce that it has completed its recent efforts to refocus the Company to exploring and developing precious metals projects in Canada.
As previously announced, the Company has acquired several promising mineral projects targeting gold, silver, and palladium and platinum (PGM’s) in some of the most active exploration and mining districts in northern Ontario (Marathon and Thunder Bay Mining Districts). This includes the Starr Project (gold and silver) and Richview Pine and Sammy Ridgeline Projects (palladium and platinum) to complement its existing Big Mac Gold Project in the Golden Triangle region of British Colum
Press release content from Business Wire. The AP news staff was not involved in its creation.
Turn Therapeutics Receives Authorization to Commence Human Trial for COVID-19 Therapeutic Candidate
January 21, 2021 GMT
LOS ANGELES (BUSINESS WIRE) Jan 21, 2021
Turn Therapeutics, a biotechnology company specializing in advanced wound care and infection control, today announced the initiation of a two-part, four-arm, human safety and efficacy trial for its flagship product, Hexagen, to be used in the fight against COVID-19. This randomized, placebo-controlled trial will enroll approximately 100 mild to moderate COVID-19 patients and 50 healthcare workers across four leading hospitals in Panama, including internationally recognized Gorgas Memorial Institute of Health Studies ( GMH ), which will also serve as the central laboratory for sample analysis.